scholarly journals Systematic review: the safety and efficacy of hyperbaric oxygen therapy for inflammatory bowel disease

2014 ◽  
Vol 39 (11) ◽  
pp. 1266-1275 ◽  
Author(s):  
P. S. Dulai ◽  
M. W. Gleeson ◽  
D. Taylor ◽  
S. D. Holubar ◽  
J. C. Buckey ◽  
...  
Keyword(s):  
Systematic Review ◽  
Inflammatory Bowel Disease ◽  
Hyperbaric Oxygen ◽  
Bowel Disease ◽  
Hyperbaric Oxygen Therapy ◽  
Oxygen Therapy ◽  
Safety And Efficacy ◽  
Inflammatory Bowel

Hyperbaric oxygen therapy in inflammatory bowel disease

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Anupam Kumar Singh ◽  
Daya Krishna Jha ◽  
Anuraag Jena ◽  
Praveen Kumar-M ◽  
Shaji Sebastian ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Hyperbaric Oxygen ◽  
Bowel Disease ◽  
Hyperbaric Oxygen Therapy ◽  
Oxygen Therapy ◽  
Inflammatory Bowel

The Effectiveness and Safety of Hyperbaric Oxygen Therapy in Various Phenotypes of Inflammatory Bowel Disease: Systematic Review With Meta-analysis

2021 ◽  
Author(s):  
Jeffrey McCurdy ◽  
Kevin Chin Koon Siw ◽  
Rana Kandel ◽  
Sarah Larrigan ◽  
Greg Rosenfeld ◽  
...  
Keyword(s):  
Systematic Review ◽  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Hyperbaric Oxygen Therapy ◽  
Oxygen Therapy ◽  
Meta Analysis ◽  
Controlled Trials ◽  
Study Quality ◽  
Randomized Controlled ◽  
Inflammatory Bowel

Abstract Background Accumulating evidence suggests that hyperbaric oxygen therapy (HBOT) may be effective for inflammatory bowel disease (IBD). Our systematic review aimed to quantify the effectiveness and safety of HBOT in various IBD phenotypes. Methods We performed a proportional meta-analysis. Multiple databases were systematically searched from inception through November 2020 without language restriction. We included studies that reported effectiveness and/or safety of HBOT in IBD. Weighted summary estimates with 95% confidence intervals (Cis) were calculated for clinical outcomes for each IBD phenotype using random-effects models. Study quality was assessed using the Cochrane evaluation handbook and National Institute of Health criteria. Results Nineteen studies with 809 patients total were eligible: 3 randomized controlled trials and 16 case series. Rates of clinical remission included 87% (95% CI, 10–100) for ulcerative colitis (n = 42), 88% (95% CI, 46–98) for luminal Crohn’s disease (CD, n = 8), 60% (95% CI, 40–76) for perianal CD (n = 102), 31% (95% CI, 16–50) for pouch disorders (n = 60), 92% (95% CI, 38–100) for pyoderma gangrenosum (n = 5), and 65% (95% CI, 10–97) for perianal sinus/metastatic CD (n = 7). Of the 12 studies that reported on safety, 15% of patients (n = 30) had minor adverse events. Study quality was low in the majority of studies due to an absence of comparator arms, inadequate description of concomitant interventions, and/or lack of objective outcomes. Conclusions Limited high-quality evidence suggests that HBOT is safe and associated with substantial rates of clinical remission for multiple IBD phenotypes. Well-designed randomized controlled trials are warranted to confirm the benefit of HBOT in IBD.

scholarly journals Letter: off-label use of hyperbaric oxygen therapy in inflammatory bowel disease

2020 ◽  
Vol 52 (1) ◽  
pp. 215-216 ◽  
Author(s):  
Corine A. Lansdorp ◽  
Christianne J. Buskens ◽  
Krisztina B. Gecse ◽  
Geert R. A. M. D’Haens ◽  
Rob A. van Hulst
Keyword(s):  
Inflammatory Bowel Disease ◽  
Hyperbaric Oxygen ◽  
Bowel Disease ◽  
Hyperbaric Oxygen Therapy ◽  
Oxygen Therapy ◽  
Off Label Use ◽  
Off Label ◽  
Inflammatory Bowel ◽  
Label Use

P-135 Hyperbaric Oxygen Therapy for the Treatment of Inflammatory Bowel Disease

2013 ◽  
Vol 19 ◽  
pp. S77-S78
Author(s):  
Parambir Dulai ◽  
Michael Gleeson ◽  
Dean Taylor ◽  
Jay Buckey ◽  
Siegel Corey
Keyword(s):  
Inflammatory Bowel Disease ◽  
Hyperbaric Oxygen ◽  
Bowel Disease ◽  
Hyperbaric Oxygen Therapy ◽  
Oxygen Therapy ◽  
Inflammatory Bowel

Safety and Efficacy of Bariatric Surgery in Inflammatory Bowel Disease Patients: a Systematic Review and Meta-analysis

2020 ◽  
Vol 30 (10) ◽  
pp. 3872-3883 ◽  
Author(s):  
Rajat Garg ◽  
Babu P. Mohan ◽  
Suresh Ponnada ◽  
Amandeep Singh ◽  
Ali Aminian ◽  
...  
Keyword(s):  
Systematic Review ◽  
Bariatric Surgery ◽  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Meta Analysis ◽  
Safety And Efficacy ◽  
Inflammatory Bowel

An updated systematic review and meta-analysis about the safety and efficacy of infliximab biosimilar, CT-P13, for patients with inflammatory bowel disease

2019 ◽  
Vol 34 (10) ◽  
pp. 1633-1652 ◽  
Author(s):  
Mahmoud Ahmed Ebada ◽  
Abdelmagid M. Elmatboly ◽  
Ahmed Said Ali ◽  
Ahmed Mohamed Ibrahim ◽  
Notila Fayed ◽  
...  
Keyword(s):  
Systematic Review ◽  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Meta Analysis ◽  
Safety And Efficacy ◽  
Inflammatory Bowel

Sa1838 SAFETY AND EFFICACY OF CONTRACEPTIVE USE IN INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW

2020 ◽  
Vol 158 (6) ◽  
pp. S-446-S-447
Author(s):  
Amanda Israel ◽  
Chelsie Warshafsky ◽  
David T. Rubin ◽  
Lisa B. Malter
Keyword(s):  
Systematic Review ◽  
Inflammatory Bowel Disease ◽  
Bowel Disease ◽  
Contraceptive Use ◽  
Safety And Efficacy ◽  
Inflammatory Bowel
Sign in / Sign up

Export Citation Format

Share Document